Post job

Optimer Pharmaceuticals's revenue is $144.0 million.

What is Optimer Pharmaceuticals's revenue?

Optimer Pharmaceuticals's annual revenue is $144.0M. Zippia's data science team found the following key financial metrics about Optimer Pharmaceuticals after extensive research and analysis.
  • Optimer Pharmaceuticals has 281 employees, and the revenue per employee ratio is $512,456.
  • Optimer Pharmaceuticals peak revenue was $144.0M in 2024.

On this page

Peak revenue
$144.0M (2024)
Company peak revenue
Revenue / employee
$512,456
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$144.0M (2024)
Company peak revenue
Revenue / employee
$512,456
Company revenue / employee

Optimer Pharmaceuticals financing

Optimer Pharmaceuticals received early financing of $32.0M on 2001-09-24.

SeriesRound sizeDate
Series B$32M09/2001
Series C$12M03/2005
Series D$22.2M12/2005

Optimer Pharmaceuticals investors

InvestorsSecurity type
China Development Industrial Bank (CDIB)Series B
ProQuest InvestmentsSeries B
ENDO INTERNATIONAL PLCSeries C
China Development Industrial Bank (CDIB)Series D
SB Life ScienceSeries D
STRATEGIC GLOBAL INVESTMENTSSeries D
Fubon BankSeries D
ProQuest InvestmentsSeries D
Lurie Investment FundSeries D
BB Biotech VenturesSeries D
YFY Biotech Management CompanySeries D

Optimer Pharmaceuticals competitors

Optimer Pharmaceuticals's top competitor, Regeneron, earned an annual revenue of $14.2B.

Optimer Pharmaceuticals's smallest competitor is Onconova Therapeutics with revenue of $226.0K last year.

Optimer Pharmaceuticals revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Optimer Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Optimer Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Optimer Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Optimer Pharmaceuticals. The data presented on this page does not represent the view of Optimer Pharmaceuticals and its employees or that of Zippia.

Optimer Pharmaceuticals may also be known as or be related to OPTIMER PHARMACEUTICALS INC and Optimer Pharmaceuticals.